Harmala alkaloid Dosage Guide

fatal interactions with many common drugs. They can cause serotonin syndrome or hypertensive crisis when combined with almost any antidepressant, stimulant, common migraine medication, certain herbs, most cold medicine (including decongestants, antihistamines, and cough syrup), nicotine, caffeine, etc. Sedatives are likely easier tolerated, but potentiation should be expected. - Cholinergics Acetylcholinesterase inhibitors (AChEIs) combined with cholinergic substances can result in a cholinergic crisis. Banisteriopsis caapi and *Peganum harmala* contain harmaline and harmine. Both alkaloids are acetylcholinesterase inhibitors (AChEIs). When intravenously injected into mice, the LD50 of harmine is 38mg/kg. There is no data for the other harmala alkaloids in humans or animals. It is strongly recommended that one use harm reduction practices when using this drug. There is no tolerance built up with harmala alkaloid use. There are no real reports of addiction to harmala alkaloids. Harmala alkaloids and their natural sources are legal in most parts of the world. - Australia:** Harmala alkaloids are Schedule 9 drugs under *POISONS STANDARD of DECEMBER 2019*. HARMALA ALKALOIDS except in herbs, or preparations, for therapeutic use: - containing 0.1 per cent or less of harmala alkaloids; or - in divided preparations containing 2 mg or less of harmala alkaloids per recommended daily dose. - Canada:** Harmala alkaloids are Schedule III drugs. - France:** Possession and sale of harmala alkaloids is illegal. - Responsible use - Beta-Carbolines - Psychedelics - Tryptamines - Phenethylamines - Lysergamides - Harmala alkaloids - Harmala alkaloids (Wikipedia) - Harmaline (Wikipedia) - Harmine (Wikipedia) - Tetrahydroharmine (Wikipedia) - Harmala Alkaloids (Erowid Vault) - Harmaline (TiHKAL / Isomer Design) - Harmine (TiHKAL / Isomer Design) - Tetrahydroharmine (TiHKAL / Isomer Des